Granisetron Transdermal: What Should I Tell My Healthcare Provider?
- A bowel blockage (obstruction)
- Liver disease, such as liver failure, cirrhosis, or hepatitis
- Any allergies, including allergies to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
- Breastfeeding.
Make sure to tell your healthcare provider about any other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Specific Warnings and Precautions
Some warnings and precautions to be aware of prior to taking
granisetron transdermal include the following:
- Granisetron transdermal can mask the symptoms of an intestinal blockage. If you are at risk for an intestinal blockage, your healthcare provider might want to monitor you more closely.
- Granisetron transdermal can interact with a few other medications (see Drug Interactions With Granisetron Transdermal for more information).
- If you have liver disease, your body may not metabolize this drug as well as it should. Therefore, you may require extra monitoring by your healthcare provider and you may need to take a lower granisetron transdermal dosage. However, most people with liver problems do not need a lower dosage of granisetron transdermal.
- Never cut a granisetron transdermal patch or use a patch that has been cut or torn in any way.
- Make sure to keep the patch covered by clothing (protected from sunlight). Also, be sure to protect the area of the skin from sunlight for 10 days after you have removed the patch (to avoid a potential skin reaction).
- Minor skin reactions due to the patch are probably nothing to worry about. However, if you experience a severe skin reaction (or a reaction that covers your entire body), remove the patch immediately and contact your healthcare provider.
- Granisetron transdermal is considered a pregnancy Category B medication. This means that it is probably safe for use during pregnancy, although the full risks are not known (see Sancuso and Pregnancy).
- It is not known if granisetron transdermal passes through breast milk. Therefore, if you are breastfeeding or plan to start breastfeeding, discuss this with your healthcare provider prior to taking the drug (see Sancuso and Breastfeeding).
